Wedgewood Pharmacy Compounded veterinary medications recall: Potential Potency Issues
Potential Potency Issues
The hazard: Potency, impurity or stability failure
The recall concerns the strength or purity of the medicine rather than contamination of it, which changes what you should do about a dose you have already taken.
What the notice says: Hazard Statement: The health risks involved with low potency can include ineffective treatment and the health risks involved with high potency can include toxicity or overdose.
Why it matters: The product failed a specification test: it may contain more or less active ingredient than the label states, carry an impurity, or degrade before its expiry date. A sub-potent dose can leave a condition untreated; a super-potent one can cause an overdose.
Symptoms and when to call a doctor
The risk depends entirely on the drug. For a medicine where dose matters closely — a blood thinner, an anti-epileptic, a thyroid or heart medicine, insulin — talk to your prescriber before changing anything. Seek urgent care if you have symptoms that suggest too much drug, or if the condition the medicine controls starts breaking through.
This page is general information, not medical advice. If you feel unwell, a clinician who can see you is the only person able to judge your case.
Recall details
- Published
- October 21, 2026
- Risk level
- Elevated risk
- Issued by
- U.S. Food and Drug Administration
- Brand
- Wedgewood Pharmacy
- Product type
- Veterinary drugs
- Distribution
- Nationwide
Products covered by this recall
Compounded veterinary medications
What the company announced
SWEDESBORO, N.J., (October 21, 2026) - Wedgewood Pharmacy LLC ("Wedgewood") is recalling certain compounded veterinary medications within expiry at the provider/customer level due to inconsistencies in the reliability of certain analytical testing data generated by their laboratory, potentially resulting in subpotent and/or superpotent products. The affected products were shipped between February 18, 2026 and October 6, 2026 to veterinary practices, pharmacies, and other customers nationwide in the U.S. The issue was discovered through Wedgewood’s own quality processes. A complete list of affected products (including powders, pastes, oral suspensions, injectables, ophthalmic ointments and solutions, ear solutions and suspensions, topical sprays, and gels), lot numbers, and expiration dates are available at www.wedgewood.com/recall-lookup/ . The products involved are intended for companion, equine, exotic, zoo, wildlife, and aquatic animals. They are not intended for use in food-producing animals.
Hazard Statement: The health risks involved with low potency can include ineffective treatment and the health risks involved with high potency can include toxicity or overdose. To date, Wedgewood has received 98 complaints, of which 7 are serious. Customers should contact their veterinarians if they have medical concerns.
For customers: Wedgewood has engaged Sedgwick to support the coordination of this recall. Sedgwick is notifying affected customers via email and mail and is arranging a refund or, where possible, replacement of recalled products. Animal owners who have received affected product should stop use, retain the product, and contact Wedgewood’s recall services by phone at 866-562-5931 Monday through Friday 8am – 9pm ET and Saturday 9am to 5pm ET.
For businesses: Veterinary practices, pharmacies, and other customers should immediately examine their inventory, quarantine any affected product and contact Wedgewood’s recall services by phone at 866-562-5931 Monday through Friday 8am – 9pm ET and Saturday 9am to 5pm ET. Veterinary practices or pharmacies who have further dispensed affected product should identify and notify their customers of the recall.
For clinical alternatives: Wedgewood is working to help customers, veterinarians, and pet owners maintain continuity of care, including identifying clinically appropriate alternatives where available. To identify alternative treatment options, customers can contact Sedgwick by phone at 866-562-5931 Monday through Friday 8am – 9pm ET and Saturday 9am to 5pm ET. Sedgwick will refer any clinical questions to Wedgewood’s care team.
This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.
Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA at 1888-FDA-VETS or online at http://www.FDA.gov/reportanimalae .
Reproduced from the company announcement posted on fda.gov. Links and contact forms in the original are not repeated here; the official notice below has them.
What to do about Potency
Wedgewood Pharmacy — The recall concerns the strength or purity of the medicine rather than contamination of it, which changes what you should do about a dose you have already taken.
- Check the lot number on your pack against the codes listed above before you do anything else.
- Call your prescriber or pharmacist and ask whether to swap the lot, re-test, or change nothing.
- Keep the carton and the leaflet — the lot number is usually printed only on the outer pack.
- Report any change in how the medicine is working to FDA MedWatch, which is where most of these signals originate.
Getting a replacement supply
Do not let a refund question interrupt your treatment. Deal with the supply first and the money second.
- Call the pharmacy before you run low. They can see which lot they dispensed to you and will usually swap it the same day.
- Insurers do not normally count a recall replacement against a refill limit. If one is refused, ask the pharmacist to call it through as a recall override.
- Over-the-counter products are refunded at the till like any other purchase; the recall notice on your phone is enough to explain the return.
- If the manufacturer runs a direct reimbursement form, it will be linked from the official notice on this page.
Remedy named in the notice: Sedgwick is notifying affected customers via email and mail and is arranging a refund or, where possible, replacement of recalled products.
Company contact: Wedgewood Pharmacy, LLC. — Consumers: Sedgwick, 866-562-5931
The official notice
This page summarises a notice published by U.S. Food and Drug Administration. The agency notice is the authoritative version — read it before you act, and treat it as the final word if anything here looks different.
Open the FDA — Company recall announcements record U.S. Food and Drug Administration recalls
Questions people ask about this recall
Why was Wedgewood Pharmacy veterinary drugs recalled?
Potential Potency Issues Hazard Statement: The health risks involved with low potency can include ineffective treatment and the health risks involved with high potency can include toxicity or overdose.
How do I know if I have the recalled product?
The notice does not publish package codes for this recall. Compare the product name, size and the purchase window against the official FDA — Company recall announcements record, and contact the company if you are unsure.
What should I do with it right now?
Check the lot number on your pack against the codes listed above before you do anything else.
Can I get my money back?
The notice says: Sedgwick is notifying affected customers via email and mail and is arranging a refund or, where possible, replacement of recalled products.
Where was the recalled product sold?
It was distributed nationwide.
Related recalls
-
Elevated risk · 2+ years ago
Sagent Docetaxel Injection, USP recall: Potential presence of particulate matter
Potential presence of particulate matter
-
Elevated risk · 2+ years ago
Hospira Buprenorphine Hydrochloride Injection Carpuject Units and Labetalol recall: Device & Drug Safety – Potential Packaging Defect
Device & Drug Safety – Potential Packaging Defect
-
Elevated risk · 3+ years ago
Merck Animal Health Banamine recall: Potential presence of particulate matter
Potential presence of particulate matter
-
Elevated risk · 9 days ago
Ultimate Forza Male Supplement recall: Product contains undeclared Sildenafil, Tadalafil, and Dapoxetine
Product contains undeclared Sildenafil, Tadalafil, and Dapoxetine
-
Class II · 12 days ago
Houston Rx LLC Sermorelin, 1 mg/mL, 10 ml vial, Sterile injectable solution recall: Lack of process control
Lack of process control
-
Class II · 12 days ago
Teva Pharmaceuticals USA, Inc Metoclopramide Tablets, USP, 5 mg recall: Presence of Foreign Tablets/Capsules
Presence of Foreign Tablets/Capsules